Comparison of Immunohistochemical Expression of Epidermal Growth Factor Receptor in Benign and Malignant Salivary Gland Tumors
DOI:
https://doi.org/10.35845/abms.2022.2.260Abstract
Objective:
To compare the immunohistochemical expression of epidermal growth factor receptor (EGFR) in benign and malignant salivary gland tumors.
Methodology:
A total of 100 cases of benign and malignant salivary gland tumors (50 each) were retrieved from histopathology lab of Peshawar Medical College, Peshawar (PMC) and Pakistan Institute of Medical Sciences, Islamabad (PIMS). Their clinical information such as gender, age and site of tumor was recorded and Hemotoxylin and eosin examination was done to confirm the diagnosis. Total immunoreactivity score of EGFR expression was determined as the sum of the staining percentage and intensity.
Results:
Among 100 cases included in our study, EGFR immunopositivity was seen in 69% (n=69) of cases collectively of both Benign & Malignant Salivary Gland Tumors. Statistically, a strong correlation was observed between EGFR expression and salivary gland tumors (P≤0.05).
Conclusion:
This research concludes that malignant salivary gland tumors (MSGTs) show a higher EGFR expression. Positive EGFR expression seen in benign salivary gland tumors (BSGTs) might indicate their aggressive behavior, recurrence and epithelial proliferation especially in Pleomorphic adenoma cases.
Key words:
EGFR, Immunohistochemistry, Mucoepidermoid Carcinoma, Pleomorphic Adenoma, Salivary gland tumors
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Aysha Khitab, Sadaf Alam, Sabeen Nasir, Imad Ali, Maria Hanif, Mehreen Malik
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may Share-copy and redistribute the material in any medium or format and Adapt-remix, transform, and build upon the material. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
. 
